By targeting three pathways, it suppresses appetite, improves glucose control and boosts calorie burning more effectively than current simple or dual agonists
Bear Case Subdued sales growth, persistent capacity issues, or in-line-to-weak guidance especially amid sector rotation could lead to further downside pressure
This dual action ensures that the skin remains soft, supple, and well-nourished, even after cleansing
In March 2024, we announced positive results from this Phase 1 MAD clinical trial of the oral tablet formulation of VK2735
The diagnostic process typically involves: Clinical history taking, focusing on symptoms (fatigue, neurological changes, dietary habits) Physical examination for signs of anaemia or neurological impairment Blood tests including full blood count, serum B12, and often folate levels Additional investigations such as intrinsic factor antibodies or parietal cell antibodies if pernicious anaemia is suspected For borderline results, additional tests like holotranscobalamin (active B12) may be considered NICE guidance recommends that treatment should commence based on clinical presentation if neurological symptoms are present, without waiting for laboratory confirmation, as delays can result in irreversible nerve damage
A clumped peptide is not necessarily degraded, but moisture exposure increases the likelihood of other degradation pathways
